Last reviewed · How we verify
NCT04855383
Intramuscular Injection of Human Chorionic Gonadotropin in Frozen Embryo Transfer Cycles
NA trial testing The effect of intramuscular injection of triple doses of human chorionic gonadotropin in frozen embryo transfer cycles in Embryo Implantation in 200 participants. Completed in 20 June 2023.
22 August 2022
Quick facts
| Lead sponsor | Royan Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 1 July 2020 |
| Primary completion | 22 August 2022 |
| Estimated completion | 20 June 2023 |
| Sites | 1 location across Iran |
Drugs / interventions tested
- The effect of intramuscular injection of triple doses of human chorionic gonadotropin in frozen embryo transfer cycles
Conditions studied
- Embryo Implantation — all drugs for Embryo Implantation →
Sponsor
Royan Institute
Who can join
Adults 20 to 40, female only, with Embryo Implantation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a randomized controlled clinical trial to compare the pregnancy outcomes of infertile women with frozen embryo transfer. The study population in frozen embryo transfer cycles receive three doses of human chorionic gonadotropin (HCG) to recognize the effectiveness of HCG on pregnancy outcomes in Reproductive Biomedicine Research Center, Royan institute, Tehran Iran.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04855383
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Embryo Implantation
Currently open trials in the same condition.
- NCT04721522 — The Impact of Endometrial Compaction on Assisted Reproductive Technology Outcome · recruiting
Other Royan Institute trials
Trials by the same sponsor.
- NCT06199024 — Cinnamon and COH in PCOS Women Underdoing IVF/ICSI Cycles · NA · unknown
- NCT06202547 — Intra-ovarian Injection of MSC-EVs in Idiopathic Premature Ovarian Failure · Phase 1, PHASE2 · unknown
- NCT05460858 — NAC Effect on Infertile Women With Endometrioma · Phase 3 · unknown
- NCT04600986 — Repeated Doses of GnRH Agonist as Oocyte Triggering in Antagonist Protocol for Patients With Polycystic Ovary Syndrome · NA · completed
- NCT04366063 — Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome · Phase 2, PHASE3 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04855383 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Royan Institute
- Last refreshed: 5 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04855383.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing